MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 67 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $23 | -100.0% | 46,023 | -87.9% | 0.00% | -100.0% |
Q1 2021 | $400,000 | -53.2% | 380,658 | -39.4% | 0.01% | -25.0% |
Q4 2020 | $854,000 | +5237.5% | 627,938 | +2879.4% | 0.01% | – |
Q2 2020 | $16,000 | -91.8% | 21,076 | -93.5% | 0.00% | -100.0% |
Q1 2020 | $195,000 | -81.9% | 324,164 | -31.5% | 0.01% | -45.0% |
Q4 2019 | $1,075,000 | +2459.5% | 473,445 | +1139.4% | 0.02% | +566.7% |
Q1 2019 | $42,000 | – | 38,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |